AI assistant
CONTROL BIONICS LIMITED — Capital/Financing Update 2021
Oct 19, 2021
64611_rns_2021-10-19_70e6c489-8b9c-4b56-82c3-44b8ad2c4540.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
20 October 2021
==> picture [146 x 44] intentionally omitted <==
ASX ANNOUNCEMENT
Introduction of rental alternative to Australian market
Control Bionics Limited (ASX:CBL) is pleased to announce that it has introduced a facility whereby Australian customers can rent CBL products.
The introduction of a rental model has been driven by a number of Australian customers having access to CBL products delayed as a result of the time taken to obtain funding from NDIS or other external funders.
The rental model allows customers to obtain the use of CBL products immediately. The products can continue to be rented for a minimum period of three months and a maximum period of 12 months. Once third-party funding is obtained, the rented units are purchased by the customers.
CBL expects that the introduction of the rental model will accelerate the penetration of CBL products in the Australian market.
The products which will be subject to the rental model include a number of CBL’s world class AAC product lines including:
==> picture [151 x 66] intentionally omitted <==
NeuroNode Trilogy Eye Gaze + NeuroNode[3] (Windows w/Grid 3)
==> picture [156 x 115] intentionally omitted <==
==> picture [155 x 114] intentionally omitted <==
==> picture [150 x 55] intentionally omitted <==
NeuroNode Duo Multi-modal Scanning (Windows/iOS)
==> picture [146 x 44] intentionally omitted <==
==> picture [121 x 52] intentionally omitted <==
Eye Gaze Duo (Windows)
==> picture [120 x 108] intentionally omitted <==
This announcement was authorized by the CEO, Rob Wong.
Investors
Brett Crowley - Company Secretary [email protected]
Business/Client Inquiries
Rob Wong - CEO [email protected]
For further information visit the website: https://www.controlbionics.com/
About Control Bionics:
Control Bionics is an assistive technology device company that enables people with communication challenges to participate more fully in daily life. It’s augmentative and alternative communication (AAC) offerings help people with a range of conditions to find their ‘voice.’ Control Bionics’ Trilogy product line is the only AAC product to harness three modalities—touch, eye, and NeuroNode control — giving users the ultimate, personalized opportunity to express themselves.